OSCR Oscar Health, Inc.

Q3 2025 10-Q

Filed: Nov 6, 2025Period ending Sep 30, 2025

Financials

Hospital & Medical Service PlansSEC EDGAR

Oscar Health, Inc. (OSCR) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 6, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Revenue not specified, no YoY comparison provided in the text
• Net investment income $53.2M for Q3 2025 vs $50.3M Q3 2024, $153.3M for 9M 2025 vs $143.3M 9M 2024

+3 more insights

Risk Factors

• New risk from CMS Program Integrity Rules enacted June 25, 2025, causing stricter APTC eligibility verification and shortening open enrollment impacting membership
• Increased estimate of risk adjustment transfer as of Sept 30, 2025 reflects worsening market morbidity, raising potential capital contribution needs and liquidity pressures

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$9M

Net Income

-$137M

Operating Margin

-1468.6%

Net Margin

-1561.8%

ROE

-13.4%

Total Assets

$5.7B

Source: XBRL data from Oscar Health, Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on Oscar Health, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.